MDxHealth is trading 7.36% higher at $0.20, amid a broader market advance; no direct link to the move has been reported.
- Broader markets rose on October 26 as oil eased and investors focused on corporate earnings and the Federal Reserve meeting.
- The latest company news found was the October 15 preliminary third-quarter update and suspension of full-year revenue guidance; it does not establish a reason for the gain.